Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Nuwiq, Anti-Haemophilic Factor (recombinant) for the Treatment of Haemophilia A

Drug Name (Brand / Generic)

Nuwiq, anti-haemophilic factor (recombinant)

Developed by

Octapharma USA

Therapy Class

Recombinant anti-haemophilic factor (blood coagulation factor VIII)

Current Indication

Haemophilia A

Market Sector


Development Status

Approved in the US, Europe and many other countries

Go Top